SRRK- Scholar Rock Holding Corporation
Scholar Rock Holding Corporation (SRRK) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. SRRK is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.37M | $304.82M | - | |
| CEO | 1.54M | $73.80M | - | |
| COO | 620.1K | $29.68M | - | |
| Pres | 595.8K | $28.52M | - | |
| CFO | 583.2K | $27.92M | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Vaishnaw Akshay56 | President Of R&D | Sell | 6,750 | $29.72 | $200,612.03 | -0.5% | +15.5% | +65.2% | |
| Apr 25, 2025 | Sacco Tracey | Chief Commercial Officer | Sale+OE | 5,000 | $32.83 | $164,130.79 | -3.4% | +19.2% | +41.7% | |
| Mar 24, 2025 | Sacco Tracey | Chief Commercial Officer | Sale+OE | 6,500 | $33.08 | $215,014.05 | -4.2% | -1.6% | +25.1% | |
| Mar 24, 2025 | Moore Erin | Interim Pfo And Pao | Sale+OE | 13,564 | $33.12 | $449,236.97 | -14.1% | -1.6% | +25.1% | |
| Mar 17, 2025 | Peng Katie | Director | Sell | 1,006 | $34.42 | $34,626.92 | -3.2% | -7.5% | +17.3% | |
| Mar 10, 2025 | Myles Edward H57 | COO &CFO | Sale+OE | 142,292 | $35.62 | $5,068,974.19 | -36.1% | -3.1% | +27.4% | |
| Feb 19, 2025 | Qatanani Mo | Chief Scientific Officer | Sale+OE | 72,645 | $37.37 | $2,714,767.40 | -12.4% | -17.0% | +25.5% | |
| Feb 18, 2025 | Parlavecchio Caryn | CHRO | Sell | 5,296 | $36.83 | $195,046.38 | -3.6% | -18.4% | +27.1% | |
| Feb 18, 2025 | Myles Edward H57 | COO &CFO | Sell | 7,809 | $36.83 | $287,597.66 | -5.3% | -18.4% | +27.1% | |
| Feb 18, 2025 | Ho Junlin | General Counsel | Sell | 5,742 | $36.83 | $211,472.12 | -2.9% | -18.4% | +27.1% |